Such forward-looking statements which may relate to NextNav forecast of future results, future prospects, developments and business strategies are subject to known and unknown risks, uncertainties and ...

Thank you, Jenny, and thank you all for joining us today. The strength of the company's stem cell science and success in multiple clinical trials across several indications positions Longeveron to be ...

We reached an important milestone in Q4 ahead of our prior expectations. During the quarter, a second customer adopted our AI-driven solution for manufacturing process development known as FTCO. This ...

Longeveron Inc. (NASDAQ:LGVN) Q4 2025 Earnings Call Transcript March 17, 2026 Longeveron Inc. beats earnings expectations.

IceCure Medical Ltd (NASDAQ:ICCM) Q4 2025 Earnings Call Transcript March 17, 2026 IceCure Medical Ltd misses on earnings expectations. Reported EPS is $-0.06 EPS, expectations were $-0.05. Operator: ...

Brian Ossenbeck JPMorgan Chase & Co, Research Division. All right. Everybody can take your seats, please. We're going to go ahead and get started with our next presentation. So Un ...

Every spring, thousands of students with perfect grades and near-perfect test scores open rejection letters from the most ...

NextNav Inc. (NASDAQ:NN) Q4 2025 Earnings Call Transcript March 17, 2026 NextNav Inc. beats earnings expectations. Reported EPS is $-0.13, expectations were $-0.15. Operator: Hello, and thank you for ...

Joining me on today’s call are Sean Nolan, Taysha Gene Therapies, Inc.'s Chief Executive Officer; Sukumar Nagendran, ...

Bank of America Global Industrials Conference 2026 March 18, 2026 6:30 AM EDTCompany ParticipantsJennifer Parmentier ...

Silvaco Group, Inc. Common Stock (NASDAQ:SVCO) Q4 2025 Earnings Call Transcript March 12, 2026 Silvaco Group, Inc. Common Stock beats earnings expectations. Reported EPS is $-0.03, expectations were $ ...

Title X is a 56-year-old federal grant program that supports thousands of clinics that provide birth control and STI testing ...